JOHN R. MURPHY - 21 Mar 2023 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ John R. Murphy
Issuer symbol
CVKD
Transactions as of
21 Mar 2023
Net transactions value
+$13,900
Form type
4
Filing time
22 Mar 2023, 16:01:06 UTC
Previous filing
16 Mar 2023
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVKD Common Stock Purchase $13,900 +10,000 +1.7% $1.39 594,792 21 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount of securities beneficially owned by Mr. Murphy following the reported transaction is correctly reported on this Form 4. The amount of securities beneficially owned by Mr. Murphy has been adjusted to correct immaterial errors in prior Form 4 filings that were filed with the Securities and Exchange Commission on January 24, 2023 and March 16, 2023.